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ABSTRACT
Meningococcal strains belonging to clonal complex cc60 are not associated with hypervirulent line-
ages and were never reported as causing disease in Latin American countries. This is the first report 
of a fatal meningitis case caused by a cc60 clonal complex meningococcus in Brazil. Despite the 
immune-compromised state of the patient, the fatal outcome here described shows the potential 
pathogenic behavior of strains belonging to this clonal complex and how compromised hosts can be 
susceptible to meningococcal infections even if the strain is not particularly invasive.
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INTRODUCTION
Meningococcal disease (MD) is a life-threat-
ening illness that may affect susceptible pa-
tients and is presented in two clinical forms: 
meningitis and septicemia. Both forms lead to 
high fatality rates ranging from 5% in devel-
oped countries to 20% in developing countries. 
When not fatal, the disease may leave severe 
sequelae. The etiological agent of MD is the 
bacterium Neisseria meningitidis (meningo-
coccus), a Gram-negative diplococcus harbor-
ing a polysaccharide capsule (PSC) which is the 
main responsible for the severity of the disease 
when it is released into the bloodstream during 
the infection process. The capsular polysaccha-
ride of the meningococcus has different bio-
chemical features which are used for typing the 
microorganism into 13 different serogroups 
according to their reactivity against specific 
antisera. Despite the great number of different 
serogroups, only 5 (A, B, C, W135 and Y) ac-
count for more than 90% of the strains produc-
ing disease worldwide. Serogrouping has been 
widely used in epidemiological studies to track 
epidemic strains and the PSC has been the 
main target of several effective vaccines against 
meningococci.
A number of proteins exposed on the 
meningococcal outer membrane have been 
used for typing strains giving an additional 
typing system dividing strains into serotypes 
and serosubtypes. Specific and consistent 
groups of serotypes and serosubtypes have 
been associated with diseases caused by cer-
tain serogroups. Also, a widely used molecu-
lar typing method called multilocus sequence 
typing (MLST) that indexes variation in multi-
ple housekeeping genes, has been successfully 
applied to track hypervirulent strains during 
outbreaks. Under this molecular approach, a 
huge database of sequence types (ST) and se-
rosubtypes has been developed and is hosted 
at the Oxford University, UK, http://neisseria.
org/nm/typing/.1,2
The so-called clonal complexes (cc) iden-
tified by MLST studies, are the main unit for 
epidemiological analysis of meningococci. A 
sub-group of cc, the so-called hyperinvasive 
or hypervirulent lineages, has been responsi-
ble for most reported meningococcal disease 
globally during the latter half of the twentieth 
century.3 Hypervirulent cc are clearly disease-
associated, but a great number of lineages has 
been only found in carriers such as the clonal 
complex 60 (cc60). Strains belonging to this 
cc have been isolated in Europe, USA and 
Canada from nasopharynx of healthy carri-
ers and from sporadic invasive disease. To our 
knowledge, cc60 was never reported in Latin 
American countries.
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CASE REPORT
We report the case of a 33 year old female patient previ-
ously diagnosed with HIV and currently on antiviral ther-
apy (AZT/3TC/lopinavir + ritonavir). She was admitted to 
a public hospital in Rio de Janeiro, Brazil, because of loss 
of consciousness with suspected bacterial meningitis, tox-
oplasmosis or cryptococcosis of the CNS. A xanthochro-
mic turbid CSF was collected on the 2nd day of admission 
and cultivated in chocolate agar with negative growth after 
48h of incubation in a 5% CO2 atmosphere. Hemoculture, 
latex seroagglutination and Ziehl-Neelsen stain (AFB) 
also turned out negative. CSF white blood cell count was 
25 cells with 80% monocytes and 20% PMN. Antibiotic 
therapy was initiated with ceftriaxone, sulfadiazine and 
pyrimethamine on the 3rd day of admission. On the 4th day 
the patient died after tracheal intubation and use of vaso-
active amines. 
A CSF aliquot collected on the 2nd day was sent to our 
laboratory for investigation of bacterial meningitis patho-
gens Neisseria meningitidis (Nm), Haemophilus influen-
zae (Hi) and Streptococcus pneumoniae (Sp) by molecular 
methods. The CSF sample was firstly inoculated into Brain 
Heart Infusion chocolate agar (Difco) enriched with 10% 
defibrinated rabbit blood at 37°C, but no growth was ob-
served after 48h in 5% CO2 atmosphere. The CSF sample 
was then used for DNA extraction and purification with 
DNeasy Blood & Tissue kit (Qiagen) and submitted to a 
multiplex-PCR approach using specific primers for de-
tection of the three bacterial agents previously described. 
The targeted genomic regions were the outer membrane 
protein nspA gene for Nm, the capsular gene bexA for Hi 
and the pneumolysin gene ply for Sp. The primers used for 
the specific PCR amplification were previously described 
for nspA,4 bexA5 and ply.6 Agarose gel electrophoresis of 
PCR products, showed a unique 481bp band confirming 
the presence of meningococcal genomic DNA in the CSF 
sample received. CSF DNA sample was also analyzed aim-
ing at genotype determination of the outer membrane pro-
tein genes porA, porB, fetA and for MLST housekeeping 
genes analysis for sequence type (ST) and clonal complex 
(cc) characterization. Serogroup prediction was also per-
formed with the DNA samples, using the SIAD-PCR pre-
viously described7 since latex agglutination test for sero-
group determination was negative for serogroups A, B, C 
and W135/Y. For PCR amplification and DNA sequencing 
of the above mentioned genes, we followed the protocol 
described in the Nesisseria.org database at http://neisseria.
org/nm/typing/. Sequencing results showed the follow-
ing genotype: C:NT:P1.22,14-6,36-2: ST-7327 (cc60). Af-
ter many attempts and protocol changes, we were not able 
to amplify porB and fetA genes. This was probably due to 
degradation of the genomic DNA extracted from the CSF 
sample received from the hospital.
DISCUSSION
Serogroups B and C meningococci, account for more 
than 90% of meningococcal cases in Brazil. Recent 
studies showed that the most frequent genotypes in 
Brazil are B:4,7:P1.19,15(P1.7,1):ST-33 (cc32) and 
C:2b:P1.3(P1.2):ST-103 (cc103), but other hyperinva-
sive cc also have been found among Brazilian isolates.8-12 
These cc, also called hypervirulent, are part of a group 
of nine hyperinvasive lineages associated with most en-
demic and epidemic meningococcal disease of the latter 
half of the twentieth century. The distribution of such 
lineages varies within geographical regions. In Brazil, 
non-hypervirulent cc causing invasive disease is not fre-
quent. According to the Neisseria.org database, 31.4% of 
the isolates characterized by MLST in Brazil (n = 271), 
belong to non-hypervirulent cc; however, none of the 
isolates was associated with cc60. Worldwide, the occur-
rence of cc60 strains is 1.9% according to the Neisseria.
org database. To date, the total number of isolates re-
ported by the database is 13,621 with only 260 strains 
belonging to cc60. The association of a specific sero-
group, serotype or subtype to cc60 as it is observed with 
hypervirulent cc is not clear. The strain isolated from 
the patient here described belongs to serogroup C, se-
rotype not determined and subtype P1.22,14-6. Among 
the 260 cc60 strains reported worldwide, only 7 (2.7%) 
were serogroup C and only one isolate (0.4%) belonged 
to families 22 and 14 of PorA VR1 and VR2, respectively. 
Also, 57% of the cc60 isolates reported in the Neisseria.
org database were recovered from carriers, while 36.5% 
from disease and other 6.5% from unknown source. The 
genetic heterogeneity found among cc60 strains has 
been more commonly observed within carrier isolates, 
while hypervirulent associated strains frequently show 
a clear link to specific serogroups and serosubtypes. It 
is noteworthy that although the meningococcal strain 
was isolated from an HIV positive patient, the organism 
showed a high virulence demonstrated by the short pe-
riod of time elapsed from the onset of symptoms to the 
patient death. This aggressive pattern is often observed 
with hypervirulent associated lineages. 
The first report of a meningococcus strain belonging 
to cc60 in Brazil, causing fatal meningitis even in an im-
mune-compromised HIV patient, may be seen as a con-
cerning issue. The fatal outcome of case here described 
shows the potential pathogenic behavior of strains be-
longing to cc60 clonal complex and how compromised 
hosts can be susceptible to meningococcal infections 
even if they are not particularly invasive.
Improvement of the public health surveillance sys-
tem would be advisable to monitor the spread of this 
clone within Brazil and adjacent Latin American coun-
tries.
Andrade, Cunha, Cavalcanti et al.
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